Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New agent with dual radiosensitizing and cytotoxic activity

Aug. 7, 2003

Design of dual Src/Abl tyrosine kinase inhibitors with antitumor and antimetastatic activity

Aug. 7, 2003

Small-molecule inhibitors of c-Met pursued at Sugen as potential anticancer agents

Aug. 7, 2003

Allos Therapeutics commences rolling NDA submission for RSR-13

Aug. 7, 2003

SCRAS scientists design new inhibitors of protein phosphatases

Aug. 7, 2003

Antimitotic drugs in early development at Pfizer

Aug. 7, 2003

FDA approves Photofrin PDT for high-grade dysplasia in Barrett's esophagus

Aug. 6, 2003

ARS scientists design GILZ-based peptides for use in cancer, inflammation, etc.

Aug. 6, 2003

New antitumor agents in Kyowa Hakko development pipeline

Aug. 6, 2003

Fulvestrant at least as effective as anastrozole in advanced breast cancer

Aug. 6, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...